Division of Thoracic Surgery, Yale-New Haven Hospital, New Haven, CT, USA; Yale University School of Medicine, New Haven, CT, USA.
Division of Thoracic Surgery, Yale-New Haven Hospital, New Haven, CT, USA; Yale University School of Medicine, New Haven, CT, USA.
Hematol Oncol Clin North Am. 2023 Jun;37(3):489-497. doi: 10.1016/j.hoc.2023.02.006. Epub 2023 Mar 22.
Thoracic surgery for non-small cell lung cancer has evolved tremendously in the past two decades. Improvements have come on multiples fronts and include a transition to minimally invasive techniques, an incorporation of neoadjuvant treatment, and a greater utilization of sublobar resection. These advances have reduced the morbidity of thoracic surgery, while maintaining or improving long-term survival. This review highlights major advances in the surgical techniques of lung cancer and the keys to optimizing outcomes from a surgical perspective.
过去二十年,非小细胞肺癌的胸外科治疗取得了巨大进展。改进措施涉及多个方面,包括向微创手术的转变、新辅助治疗的应用,以及肺段切除术的更多使用。这些进步降低了胸外科手术的发病率,同时保持或改善了长期生存。本文重点介绍肺癌外科治疗技术的主要进展,以及从外科角度优化治疗效果的关键。